Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2026)

Caris Life Sciences' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 1258.65% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $22.8 million (up 289.74% YoY), while the FY2025 annual figure was $16.5 million, up 131.63% from the prior year.
• Interest & Investment Income was $6.8 million for Q1 2026 at Caris Life Sciences, down from $7.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.4 million in Q3 2025 to a low of $503000.0 in Q1 2025.
• Historically, Interest & Investment Income has averaged $3.6 million across 3 years, with a median of $2.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income tumbled 38.71% in 2025, then jumped 1258.65% in 2026.
• A 3-year view of Interest & Investment Income shows it stood at $970000.0 in 2024, then jumped by 623.2% to $7.0 million in 2025, then decreased by 2.58% to $6.8 million in 2026.
• The last three Interest & Investment Income figures came in at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.